consider that the data support the presence of the disease in older children as well. Clearly, Bitot's spots do not always indicate the presence of active xerophthalmia in children over 6, a point made in the original patper. The extent of severe malnutrition in all age groups prompted me to examine children up to 14 in this population. It was an unprecedented situation, which I thought merited a wider sample size than normally used.
While We performed the Thrombotest (Thrombotest Owren, Eisai Co, Tokyo) for 437 babies at 2 weeks. Of the 437 babies, 263 were breast fed, 37 bottle fed, and J37 mixed fed. None of the babies had received vitamin K at any time before this study. A significant difference in the Thrombotest values of breast fed compared with bottle and mixed fed babies was obtained (mean (SD) Thrombotest values for breast fed babies=64-1 (20(0)'%o, for bottle fed=80-0 (22-7)%, and for mixed fed=73'9 (21-2)%; p<0-O1). Four of the 263 breast fed babies had Thrombotest values lower than 30%0 and these babies may be at risk from intracranial haemorrhage.
We prescribed 2 mg of vitamin K, intramuscularly or orally to 125 babies (90 breast fed, five bottle fed, and 30 mixed fed) who had low Thrombotest values of less than 60% at 2 weeks. The mean (SD) Thrombotest values for babies with each feed before and two weeks after the vitamin K, administration were 48X3 (10'0)% and 88-2 
